Radiobiological evaluation of prostate cancer IMRT and conformal-RT plans using different treatment protocols

Panayiotis Mavroidis; Georgios Komisopoulos; Courtney Buckey; Margarita Mavroeidi; Gregory P Swanson; Dimos Baltas; Nikos Papanikolaou; Sotirios Stathakis

doi:10.1016/j.ejmp.2017.07.003

Radiobiological evaluation of prostate cancer IMRT and conformal-RT plans using different treatment protocols

Phys Med. 2017 Aug:40:33-41. doi: 10.1016/j.ejmp.2017.07.003. Epub 2017 Jul 13.

Authors

Panayiotis Mavroidis¹, Georgios Komisopoulos², Courtney Buckey³, Margarita Mavroeidi⁴, Gregory P Swanson⁵, Dimos Baltas⁶, Nikos Papanikolaou⁷, Sotirios Stathakis⁷

Affiliations

¹ Department of Radiation Oncology, University of North Carolina, Chapel Hill, NC, United States; Division of Medical Physics, Karolinska Institutet & Stockholm University, Stockholm, Sweden. Electronic address: panayiotis_mavroidis@med.unc.edu.
² University Hospital of Larissa and General Hospital of Larissa, Greece.
³ Department of Radiation Oncology, University of Texas Health Sciences Center at San Antonio, TX, United States; Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, United States.
⁴ Department of Radiation Oncology, University of North Carolina, Chapel Hill, NC, United States.
⁵ Department of Radiation Oncology, University of Texas Health Sciences Center at San Antonio, TX, United States; Baylor Scott & White Healthcare Temple Clinic, Temple, TX, United States.
⁶ Division of Medical Physics, Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany; German Cancer Consortium (DKTK), Partner Site Freiburg, Germany.
⁷ Department of Radiation Oncology, University of Texas Health Sciences Center at San Antonio, TX, United States.

PMID: 28712717
DOI: 10.1016/j.ejmp.2017.07.003

Abstract

The purpose of this study is to evaluate the clinical efficacy of both step-and-shoot IMRT and 3D-Conformal Radiation Therapy modalities (CRT) in treating prostate cancer using radiobiological measures. Another aim was to estimate the risks for developing secondary malignancies in bladder and rectum due to radiotherapy from the corresponding modalities. The treatment plans of ten prostate cancer patients were developed using IMRT and CRT. For the IMRT plans, two beam energies and two treatment protocols were used (the RTOG 0415 and a most restrictive one proposed by Fox Chase Cancer Center (FCCC)). For the evaluation of these plans, the complication-free tumor control probability, the total probability of injury, the total probability of control/benefit, and the biologically effective uniform dose were employed. Furthermore, based on the dosimetric data of IMRT and CRT, the risk for secondary malignancies was calculated for bladder and rectum. The average risk for secondary malignancy was lower for the bladder (0.37%) compared to the rectum (0.81%) based on all the treatment plans of the ten prostate cancer patients. The highest average risk for secondary malignancy for bladder and rectum was for the CRT-6X modality (0.46% and 1.12%, respectively) and the lowest was for the IMRT RTOG-18X modality (0.33% and 0.56%, respectively). The ≥ Grade 2 LENT/SOMA response probability was lower for the bladder than for the rectum in all the plans. For the bladder the highest average value was for the IMRT RTOG-18X (0.9%) and the lowest was for the CRT-18X modality (0.1%). For the rectum, the highest average value was for the IMRT RTOG-6X (11.9%) and the lowest was for the IMRT FCCC-18X modality (2.2%). By using radiobiological measures it is shown that the IMRT FCCC plans had the lowest risks for normal tissue complications, whereas the IMRT RTOG had the highest. Regarding the risk for secondary malignancies, the CRT plans showed the highest values for both bladder and rectum.

Keywords: CRT; IMRT; NTCP; Prostate cancer; Radiobiological metrics; Risk for secondary cancer; TCP.

MeSH terms

Clinical Protocols
Humans
Male
Prostatic Neoplasms / radiotherapy*
Radiotherapy Dosage
Radiotherapy Planning, Computer-Assisted*
Radiotherapy, Conformal*
Radiotherapy, Intensity-Modulated*